FINHUB Insights

IEX · Q2 FY25 · Apr 1 – Jun 30, 2025

IDEX Q2 FY25: where the revenue came from and where it went

IDEX Q2 FY25: revenue $0.9B (+7% year over year). Net profit $0.1B. Largest cohort Health and Science Technologies $0.4B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Jul 30, 2025 10-Q
Sankey diagram of IDEX's income statement for Q2 FY25: revenue of $0.9 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$0.9B +7% year over year
Gross profit$0.4B 45% margin
Operating profit$0.2B 22% margin
Net profit$0.1B 15% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 0.9 100% +7%
Health and Science Technologies 0.4 44% +20%
Fluid and Metering Technologies 0.3 33% −3%
Fire and Safety Diversified… 0.2 22% +3%
Cost of revenue−0.556%
Gross profit0.445% margin+0pp
SG&A−0.224%+1pp
Operating profit0.222% margin−1pp
Net profit0.115%−2pp
Filing on EDGAR More quarters of IEX

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters